BFZ vs BRK-B

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant operational and balance sheet deterioration. Despite a high dividend yield of 5.54%, the unsustainable 526.15% payout ratio and negative profit margin of -92.96% raise severe concerns about distribution coverage. Insider activity is uniformly bearish, with over $13.96M in net selling by major holders, while technical indicators and valuation metrics suggest overvaluation relative to fundamentals. Although the Price/Book ratio is below 1, the lack of Altman Z-Score and Graham Number, combined with liquidity risks (Current Ratio: 0.07), undermines any margin of safety.

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.